Retinal Eye Drug Gets Red Light from FDA

"The U.S. Food and Drug Administration declined to approve Alimera Sciences Inc's experimental drug to treat retinal swelling in its current form, sending the biopharmaceutical company's shares down 41 percent in after-market trade," according to a post from YahooNews.